Biotechnology expert discusses current economic environment at AAPS conference

At the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference 2023, Joel Dudley, Ph.D., a Partner at Innovation Endeavors, will present a talk examining the current economic environment for biotechnology firms and leveraging A.I. for pharmaceutical and technology development.

Dudley is an expert in the biotechnology space with experience in evaluating biotechnology firms and start-ups. While at the Icahn School of Medicine, Dr. Dudley was one of the authors of a 2016 paper published in the Journal of Clinical Investigation that compared results from a blood sample tested using Theranos’ technology with traditional blood testing services. The authors found that the Theranos product “flagged tests outside their normal range 1.6× more often than other testing services.”

Prior to Innovation Endeavors, Dr. Dudley served as Chief Scientific Officer for Tempus, a health tech start-up. He was also an Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai.

“AAPS is honored to have Joel Dudley present the opening plenary for the National Biotechnology Conference,” AAPS Executive Director Tina Morris, Ph.D., said. “His insights will be valuable at a time when the biotechnology sector must shrewdly navigate a more challenging economic environment in order to continue delivering life-saving innovations to patients.”

“As an organization, AAPS strives to present quality science. Joel Dudley exemplifies a commitment to scientific ethics and leadership within our industry that we wanted to highlight at this year’s National Biotechnology Conference,” AAPS President Patrick Sinko, Ph.D., said.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>